A comprehensive medication review of a polypharmacy patient population: A cross-sectional observational study

Nimee, Frantzeska; Steier, James; Papandreou, Georgios; Skouroliakou, Maria

doi:10.1016/j.rcsop.2022.100144

Cited by 1 publication

(1 citation statement)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Additionally, pharmaceutical consultation, including the proper use of medications, the managing of side effects, and guidance on the proper use of over-the-counter (OTC) medications, was offered by licensed pharmacologists. A CDSS that consisted of integrated and evidence-based data on the Greek market medications supported the pharmacists throughout the pharmaceutical care process [28].…”

Section: Active Ingredient Excipientsmentioning

confidence: 99%

The Effect of Melatonin Supplementation on Cancer-Related Fatigue during Chemotherapy Treatment of Breast Cancer Patients: A Double-Blind, Randomized Controlled Study

Nimee,

Gioxari,

Papandreou

et al. 2024

Cancers

View full text Add to dashboard Cite

Cancer-related fatigue (CRF) is a common distressing complaint of breast cancer (BC) patients treated with chemotherapy. Nutritional quality plays a pivotal role in CRF, while increased interest towards new pharmacological agents has been observed. Melatonin, an endogenous hormone that regulates the human sleep–wake cycle, could alleviate CRF. In the present randomized, placebo-controlled 3-month trial, we investigated the effects of melatonin intake (i.e., 1 mg/day) vs. placebo in BC patients on CRF. In both arms, the Mediterranean diet (MD) was implemented. Medical history, anthropometry and blood withdrawal were performed. CRF was evaluated by the Functional Assessment of Chronic Illness Therapy—Fatigue questionnaire and MD adherence by the MedDietScore. In total, 49 BC women (median age 52 years) were recruited, namely N = 23 in the intervention arm and N = 26 in the placebo arm. At baseline, CRF was positively associated with body mass index (BMI), even when adjusted for age, waist circumference and blood indices related to disease prognosis (beta = −0.882, p = 0.003). At 3 months, both groups showed a BMI decrease (p < 0.05), but only the intervention group improved CRF compared to baseline (p = 0.003). No differences in CRF were observed between the groups. In conclusion, melatonin oral supplementation could ameliorate CRF in BC patients.

show abstract

Section: Active Ingredient Excipientsmentioning

confidence: 99%